These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26344223)

  • 1. Detection of Bulky Endogenous Oxidative DNA Lesions Derived from 8,5'-Cyclo-2'-deoxyadenosine by ³²P-Postlabeling Assay.
    Zhou GD; Moorthy B
    Curr Protoc Toxicol; 2015 May; 64():17.17.1-17.17.14. PubMed ID: 26344223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 32P-postlabeling assay for the oxidative DNA lesion 8,5'-cyclo-2'-deoxyadenosine in mammalian tissues: evidence that four type II I-compounds are dinucleotides containing the lesion in the 3' nucleotide.
    Randerath K; Zhou GD; Somers RL; Robbins JH; Brooks PJ
    J Biol Chem; 2001 Sep; 276(38):36051-7. PubMed ID: 11454870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-postlabeling analysis of DNA adducts.
    Phillips DH; Hewer A; Arlt VM
    Methods Mol Biol; 2005; 291():3-12. PubMed ID: 15502206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two ultrasensitive methods for measuring 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine in cellular DNA.
    Misra RR; Chiang SY; Swenberg JA
    Carcinogenesis; 1994 Aug; 15(8):1647-52. PubMed ID: 8055645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of DNA adducts by 32P-postlabeling and multifraction contact-transfer thin-layer chromatography.
    Laws GM; Adams SP; Nichols WW; Selden JR
    Fundam Appl Toxicol; 1994 Aug; 23(2):308-12. PubMed ID: 7982538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Phillips DH; Arlt VM
    Methods Mol Biol; 2020; 2102():291-302. PubMed ID: 31989562
    [No Abstract]   [Full Text] [Related]  

  • 11. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay.
    Reichert WL; Stein JE; French B; Goodwin P; Varanasi U
    Carcinogenesis; 1992 Aug; 13(8):1475-9. PubMed ID: 1499099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pH of the T4 polynucleotide kinase reaction on the 32P-postlabeling assay of DNA adducts.
    Lee CK; Brown BG; Bombick BR; Doolittle DJ
    Anal Biochem; 1995 May; 227(1):156-61. PubMed ID: 7668376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of 1,N6-propanodeoxyadenosine in acrolein-modified polydeoxyadenylic acid and DNA by 32P postlabeling.
    Smith RA; Williamson DS; Cerny RL; Cohen SM
    Cancer Res; 1990 May; 50(10):3005-12. PubMed ID: 2334905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the 32P-postlabeling method to detect a single adduct species as a single spot.
    Ochiai M; Sugimura T; Nagao M
    Methods Mol Biol; 2005; 291():13-9. PubMed ID: 15502207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 7-methylbenz[a]anthracene-DNA adducts formed in SENCAR mouse epidermis by 32P-postlabeling.
    Baer-Dubowska W; Vulimiri SV; Harvey RG; Cortez C; DiGiovanni J
    Carcinogenesis; 1997 Mar; 18(3):523-9. PubMed ID: 9067552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of HPLC in the 32P-postlabeling assay.
    Gorelick NJ
    Mutat Res; 1993 Jul; 288(1):5-18. PubMed ID: 7686266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase.
    Reddy MV; Bleicher WT; Blackburn GR
    Cancer Commun; 1991 Apr; 3(4):109-17. PubMed ID: 2025496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
    Funk D; Sorg BL; Lindner SC; Schmeiser HH
    Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.